Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 23
2023
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
13,748
+16.71%
|
$6,750,268
$491.69 P/Share
|
|
Feb 23
2023
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
4,414
-13.21%
|
$2,167,274
$491.69 P/Share
|
|
Feb 23
2023
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,237
+7.15%
|
$11,900,367
$491.69 P/Share
|
|
Feb 23
2023
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,572
-5.5%
|
$4,208,852
$491.69 P/Share
|
|
Feb 22
2023
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-0.63%
|
$444,080
$488.89 P/Share
|
|
Feb 22
2023
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+1.33%
|
$947,696
$488.89 P/Share
|
|
Feb 22
2023
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-1.07%
|
$187,880
$488.89 P/Share
|
|
Feb 22
2023
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
782
+2.12%
|
$381,616
$488.89 P/Share
|
|
Feb 22
2023
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
467
-1.71%
|
$227,896
$488.89 P/Share
|
|
Feb 22
2023
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
1,028
+3.64%
|
$501,664
$488.89 P/Share
|
|
Feb 22
2023
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,357
-1.66%
|
$662,216
$488.89 P/Share
|
|
Feb 22
2023
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
2,813
+3.33%
|
$1,372,744
$488.89 P/Share
|
|
Feb 22
2023
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
965
-1.78%
|
$470,920
$488.89 P/Share
|
|
Feb 22
2023
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+3.94%
|
$1,089,216
$488.89 P/Share
|
|
Feb 22
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-2.01%
|
$103,944
$488.89 P/Share
|
|
Feb 22
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
782
+6.87%
|
$381,616
$488.89 P/Share
|
|
Feb 14
2023
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
579
-1.1%
|
$284,868
$492.83 P/Share
|
|
Feb 14
2023
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
1,367
+2.53%
|
$672,564
$492.83 P/Share
|
|
Feb 14
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-1.3%
|
$63,468
$492.83 P/Share
|
|
Feb 14
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
533
+5.09%
|
$262,236
$492.83 P/Share
|
|
Feb 14
2023
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
640
-0.45%
|
$314,880
$492.83 P/Share
|
|
Feb 14
2023
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,367
+0.95%
|
$672,564
$492.83 P/Share
|
|
Feb 14
2023
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-0.79%
|
$138,252
$492.83 P/Share
|
|
Feb 14
2023
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
573
+1.59%
|
$281,916
$492.83 P/Share
|
|
Feb 14
2023
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
285
-1.08%
|
$140,220
$492.83 P/Share
|
|
Feb 14
2023
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
933
+3.4%
|
$459,036
$492.83 P/Share
|
|
Feb 14
2023
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,061
-1.33%
|
$522,012
$492.83 P/Share
|
|
Feb 14
2023
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+2.68%
|
$1,082,400
$492.83 P/Share
|
|
Feb 13
2023
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
548
-1.06%
|
$271,260
$495.35 P/Share
|
|
Feb 13
2023
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
1,942
+3.61%
|
$961,290
$495.35 P/Share
|
|
Feb 13
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-2.24%
|
$106,920
$495.35 P/Share
|
|
Feb 13
2023
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
863
+8.23%
|
$427,185
$495.35 P/Share
|
|
Feb 13
2023
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
831
-0.58%
|
$411,345
$495.35 P/Share
|
|
Feb 13
2023
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,774
+1.23%
|
$878,130
$495.35 P/Share
|
|
Feb 13
2023
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
402
-1.14%
|
$198,990
$495.35 P/Share
|
|
Feb 13
2023
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
798
+2.2%
|
$395,010
$495.35 P/Share
|
|
Feb 13
2023
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.29%
|
$165,330
$495.35 P/Share
|
|
Feb 13
2023
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
1,079
+4.0%
|
$534,105
$495.35 P/Share
|
|
Feb 13
2023
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-1.41%
|
$551,430
$495.35 P/Share
|
|
Feb 13
2023
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
2,310
+2.85%
|
$1,143,450
$495.35 P/Share
|
|
Jan 03
2023
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.29%
|
-
|
|
Jan 03
2023
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
185
+1.55%
|
-
|
|
Jan 03
2023
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
181
+3.93%
|
-
|
|
Jan 03
2023
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
181
+4.4%
|
-
|
|
Jan 03
2023
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
181
+2.04%
|
-
|
|
Jan 03
2023
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+2.75%
|
-
|
|
Jan 03
2023
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
86
+21.94%
|
-
|
|
Jan 03
2023
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
275
+0.05%
|
-
|
|
Dec 20
2022
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
10,500
-1.9%
|
-
|
|
Dec 14
2022
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-0.58%
|
$440,622
$538.36 P/Share
|